Biomaterial Database

Torasemide, a new loop diuretic, in patients with chronic renal failure. 1990

D Russo, and R M Gazzotti, and A Testa

Department of Nephrology, 2nd Faculty of Medicine, University of Naples, Italy.

Torasemide, a new loop diuretic, was administered in 9 hospitalized patients with chronic renal failure to treat both arterial hypertension and peripheral edema. The urine of 5 patients was collected over 12-hour periods to assess the long-lasting diuretic activity of torasemide. Torasemide induced a significant decrease in blood pressure and reversion of peripheral edema in all patients without adverse effects. Torasemide is a high-ceiling loop diuretic, useful in correcting extracellular fluid volume expansion in patients with chronic renal failure.

UI	MeSH Term	Description	Entries
D006973	Hypertension	Persistently high systemic arterial BLOOD PRESSURE. Based on multiple readings (BLOOD PRESSURE DETERMINATION), hypertension is currently defined as when SYSTOLIC PRESSURE is consistently greater than 140 mm Hg or when DIASTOLIC PRESSURE is consistently 90 mm Hg or more.	Blood Pressure, High,Blood Pressures, High,High Blood Pressure,High Blood Pressures
D007676	Kidney Failure, Chronic	The end-stage of CHRONIC RENAL INSUFFICIENCY. It is characterized by the severe irreversible kidney damage (as measured by the level of PROTEINURIA) and the reduction in GLOMERULAR FILTRATION RATE to less than 15 ml per min (Kidney Foundation: Kidney Disease Outcome Quality Initiative, 2002). These patients generally require HEMODIALYSIS or KIDNEY TRANSPLANTATION.	ESRD,End-Stage Renal Disease,Renal Disease, End-Stage,Renal Failure, Chronic,Renal Failure, End-Stage,Chronic Kidney Failure,End-Stage Kidney Disease,Chronic Renal Failure,Disease, End-Stage Kidney,Disease, End-Stage Renal,End Stage Kidney Disease,End Stage Renal Disease,End-Stage Renal Failure,Kidney Disease, End-Stage,Renal Disease, End Stage,Renal Failure, End Stage
D008297	Male		Males
D008875	Middle Aged	An adult aged 45 - 64 years.	Middle Age
D001794	Blood Pressure	PRESSURE of the BLOOD on the ARTERIES and other BLOOD VESSELS.	Systolic Pressure,Diastolic Pressure,Pulse Pressure,Pressure, Blood,Pressure, Diastolic,Pressure, Pulse,Pressure, Systolic,Pressures, Systolic
D002986	Clinical Trials as Topic	Works about pre-planned studies of the safety, efficacy, or optimum dosage schedule (if appropriate) of one or more diagnostic, therapeutic, or prophylactic drugs, devices, or techniques selected according to predetermined criteria of eligibility and observed for predefined evidence of favorable and unfavorable effects. This concept includes clinical trials conducted both in the U.S. and in other countries.	Clinical Trial as Topic
D004231	Diuresis	An increase in the excretion of URINE. (McGraw-Hill Dictionary of Scientific and Technical Terms, 6th ed)	Diureses
D004232	Diuretics	Agents that promote the excretion of urine through their effects on kidney function.	Diuretic,Diuretic Effect,Diuretic Effects,Effect, Diuretic,Effects, Diuretic
D004487	Edema	Abnormal fluid accumulation in TISSUES or body cavities. Most cases of edema are present under the SKIN in SUBCUTANEOUS TISSUE.	Dropsy,Hydrops,Anasarca
D005110	Extracellular Space	Interstitial space between cells, occupied by INTERSTITIAL FLUID as well as amorphous and fibrous substances. For organisms with a CELL WALL, the extracellular space includes everything outside of the CELL MEMBRANE including the PERIPLASM and the cell wall.	Intercellular Space,Extracellular Spaces,Intercellular Spaces,Space, Extracellular,Space, Intercellular,Spaces, Extracellular,Spaces, Intercellular

Related Publications

D Russo, and R M Gazzotti, and A Testa

The loop diuretic torasemide in chronic renal failure. Pharmacokinetics and pharmacodynamics.

January 1991, Drugs,

D Russo, and R M Gazzotti, and A Testa

Saluretic effect of the loop diuretic torasemide in chronic renal failure. Interdependence of electrolyte excretion.

January 1990, European journal of clinical pharmacology,

D Russo, and R M Gazzotti, and A Testa

Torasemide for diuretic treatment of advanced chronic renal failure.

January 1988, Arzneimittel-Forschung,

D Russo, and R M Gazzotti, and A Testa

Clinical pharmacology of torasemide, a new loop diuretic.

August 1987, Clinical pharmacology and therapeutics,

D Russo, and R M Gazzotti, and A Testa

Torasemide--a unique loop diuretic.

January 2001, Cardiovascular journal of South Africa : official journal for Southern Africa Cardiac Society [and] South African Society of Cardiac Practitioners,

D Russo, and R M Gazzotti, and A Testa

Loop diuretic therapy in acute and chronic renal failure.

January 1993, Journal of cardiovascular pharmacology,

D Russo, and R M Gazzotti, and A Testa

[Torasemide--new generation loop diuretic: clinical pharmacology and therapeutic application].

January 2006, Kardiologiia,

D Russo, and R M Gazzotti, and A Testa

Diuretic profile of a novel loop diuretic torasemide in rats and dogs.

January 1991, Drugs under experimental and clinical research,

D Russo, and R M Gazzotti, and A Testa

Study of the elimination kinetics of torasemide, a novel loop diuretic, in renal insufficiency.

January 1986, European journal of clinical pharmacology,